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Abstract
Attempts to characterize cellular behaviors with static, univariate measurements cannot fully
capture biological complexity and lead to an inadequate interpretation of cellular processes.
Significant biological insight can be gleaned by considering the contribution of dynamic protein
post-translational modifications (PTMs) utilizing systems-level quantitative analysis. High-
resolution mass spectrometry coupled with computational modeling of dynamic signal-response
relationships is a powerful tool to reveal PTM-mediated regulatory networks. Recent advances
using this approach have defined network kinetics of growth factor signaling pathways, identified
systems level responses to cytotoxic perturbations, elucidated kinase-substrate relationships, and
unraveled the dynamics of PTM cross-talk. Innovations in multiplex measurement capacity, PTM
annotation accuracy, and computational integration of datasets promises enhanced resolution of
dynamic PTM networks and further insight into biological intricacies.
Introduction
Systems biology aims to identify emergent properties: behaviors, such as cell phenotype,
defined by the interaction of many components in the network that are not predictable from
the analysis of any single component. The classic dogma of molecular biology, in which
information flows from DNA to RNA to proteins to coordinate the development and
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function of a cell, does not adequately explain these emergent properties, and also fails to
account for the rapid response of biological systems to altered intra- or extra-cellular
conditions. A variety of epigenetic phenomena, including protein-protein interactions,
chromatin alterations, non-coding RNAs, and post-translational modifications (PTMs),
among others, have been implicated in governing cellular responses and phenotypes.
Importantly, none of these epigenetic regulatory events can be accurately inferred from
genomic information alone [1–4]. The importance of these additional layers of non-genomic
regulation cannot be understated; dynamic epigenetic regulatory networks must be
considered to fully appreciate the complete nature of a biological system.
One well-studied mechanism by which cells acutely respond and coordinate activities is
through post-translational modification (PTM) based cellular signaling networks. The
assortment of PTMs in a eukaryotic cell is staggering, with over 600 different protein
modification types annotated in the RESID database (September 2013 release; URL http://
pir.georgetown.edu/resid/). Protein PTMs can rapidly modulate complex formation,
stability, activity, and spatial localization[4]. Integration of this vast array of PTMs
ultimately governs cellular information processing and the corresponding cellular behaviors
such as migration, apoptosis, and proliferation that are elicited [5]. Of the routinely studied
PTMs, phosphorylation, arguably the most abundant PTM in eukaryotic cells, has been
shown to drive signal transduction cascades connecting cell surface receptors to resultant
cell phenotypes [6–8]. As such, throughout this review special attention will be paid to the
role of dynamic phosphorylation in coordinating information flow within the cell and
regulating cellular response to cellular perturbations.
Identification of the altered networks underlying emergent properties typically requires
systems-level analysis entailing the collection of multivariate data which can yield
hypotheses and predictions that are beyond a scientist's intuition [9,10]. Systems level
analyses can also clarify paradoxical findings. For example, the dissection of signaling
pathways by traditional reductionist approaches can lead to apparent contradictions in the
activity or role of individual proteins. The literature is filled with examples of seemingly
conflicting results for a number of highly studied signaling components such as Notch and
MAPK [11,12]. One landmark paper from the Yaffe group demonstrated the power of
systems-level analysis by considering apoptotic regulation by c-Jun N-terminal kinase
(JNK) [13]. Through a series of multivariate sampling measurements and data-driven
computational modeling, they concluded that phospho-JNK levels could appear anti-
apoptotic, proapoptotic, or uninvolved in apoptosis depending on the `signaling state' of the
cell. Therefore, a signaling component can have a multivariate nature and response that can
only be fully understood by taking into account the context of the network in which it is
functioning. Thus, to fully comprehend the multidirectional intracellular interconnections
that exist, techniques must be employed to comprehensively detect and quantify multiple
components of a network.
The analytical tools available to unravel these details are expanding but ultimately must
satisfy minimal requirements to accurately identify and quantify many components within a
single analysis, thereby enabling quantitative analysis at a systems level. Mass spectrometry
(MS) based proteomic tools fulfill these requirements and have become a mainstay
Gajadhar and White Page 2
Curr Opin Biotechnol. Author manuscript; available in PMC 2015 August 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
technology for monitoring system level dynamics of PTMs [14,15]. As such, MS-based
strategies have helped to reveal PTM signaling networks by mapping hundreds to thousands
of PTM sites in many different cell or tissue types while simultaneously providing
quantitative abundances across multiple conditions [16].
To accurately capture information flow and regulatory networks, it is critical to consider the
dynamic nature of biological systems. A simple enumeration of the components within a
network neglects the relationships and coordination that exists as the system adapts and
responds. Cellular states are in constant flux, responding to environmental cues and genetic
changes in time and space, so techniques to measure networks in functioning cells must
strive to account for these dynamics. One way to achieve this annotation is by meticulous
experimental mapping of epigenetic changes across multiple conditions and multiple time
points following cell perturbation to gain an understanding of specific systems level
responses. This approach switches the emphasis from simply identifying the parts of the
system to examining the components that are altered between conditions of interest [17].
This information can be experimentally uncovered by grossly perturbing the state of the cell
at the molecular level with some sort of input stimuli (cue), thereby activating diverse PTM
conduits (signals) responsible for cellular decision processes and phenotypes (response).
These cue-signal-response type measurements, if monitored at the network-level and across
multiple systematic conditions, can reveal the dynamic molecular nodes and processes on
which further investigation should focus and highlight the relationship of these nodes to
quantitative phenotype data if available. As an example, we have analyzed the effects of
increased HER2 expression on the tyrosine phosphorylation network response to cell
stimulation with epidermal growth factor (EGF) or heregulin [18]. Cellular phenotype
response to stimulation was also monitored through quantitative analysis of cell migration
and proliferation. Several hundred tyrosine phosphorylation sites were quantified at 4 time
points following stimulation with each growth factor in each cell line. The cue-signal-
response data was integrated with partial least squares regression (PLSR), enabling the
identification of the phosphorylation sites that most strongly correlated with each cell
response at each time point. This approach provides putative functional assignments for
poorly characterized phosphorylation sites, and the PLSR-based model can be used to
predict response to loss of a given phosphorylation site in the network. Given the importance
of dynamic signaling networks in regulating the cellular response to perturbation, the
remainder of this article will focus on recent reports, tools and approaches relevant to
understanding system dynamics of biological processes with a particular emphasis on MS-
enabling strategies.
Dynamics of phosphorylation
Mass spectrometric analysis of protein phosphorylation is an immense analytical challenge.
Thousands of proteins are expressed in each cell, with most proteins present in multiple
different isoforms, and with each isoform potentially modified at multiple phosphorylation
sites [19,20]. Due to the transient nature and varied stoichiometry of each phosphorylation
site, it has been very difficult to generate a comprehensive catalog of all protein
phosphorylation sites in any given biological sample. It is worth mentioning that, in our
opinion, the goal of using systems-level tools to probe phosphorylation must move beyond a
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superficial `cataloging' of phosphorylation sites and phosphorylated proteins to
understanding and determining the putative phosphorylation marks that are responsive and
dynamic in nature. Thoughtful design and execution of experimental studies to understand
phospho-dynamics can provide rich insights into the underlying mechanics of a functioning
network, reveal unanticipated biological features and profoundly guide future ventures in a
way that simple indexing cannot. Here we will highlight a few recent studies have derived
biological insight to cellular signaling mechanisms through MS-based network analysis. For
instance, a recent report from the Ferrara group utilized a phospho-proteomic strategy to
dissect vascular endothelial growth factor (VEGF)-regulated phosphorylation dynamics in a
human endothelial cell model [21]. VEGF receptor signaling had been previously shown to
trigger the PI3KAKT, Raf-MEK, and Src-FAK pathways. Using a selective enrichment
schema with five immunoaffinity motif antibodies combined with quantitative mass tagging,
they selectively investigated temporal phosphorylation profiles of these three pathways upon
VEGF stimulation. This kinetic sampling allowed identification of a discrete sequence of
phosphorylation dynamics revealing membrane-proximal events, followed by nuclear and
transcription factor phosphorylation, and terminal events implying establishment of an
integrated signaling network. Furthermore, the acquisition of this network-level
phosphorylation dataset allowed resolution of molecular conduits by which VEGF signaling
may lead to RTK reprogramming in endothelial cells upon pharmacological intervention.
Another recent report used MS-based phospho-proteomics, combined with stable isotope
labeling, to survey the network changes to protein phosphorylation during cell-cycle
recovery from DNA-damaging agents [22]. Their analysis revealed 154 proteins that were
quantitatively dynamic during recovery from DNA damage–induced G2 arrest across
multiple time points. Interestingly, 84 of these proteins were previously identified in a
screen of targets phosphorylated upon DNA-damage, but only two phosphosites were shared
between the induction of DNA repair and the recovery from DNA repair. This result
suggests that PTMs governing DNA repair machinery are astonishing complex with
multisite phosphorylation often regulating diametrically opposed functions on the same
protein.
Each of the above examples used mass spectrometry to query changes in signaling networks
at the systems level. In many cases, selected kinases within the network have previously
been implicated in regulating a given cellular response. To utilize this a priori knowledge,
analog-sensitive kinases (AS-kinases) and bio-orthogonal ATP analogs can be combined
with MS-based phospho-proteomics to identify and quantify direct substrates of given
kinases [23,24]. To date, quantification of substrate phosphorylation dynamics has been
challenging due to the inability of the ATP analog to penetrate the cell membrane. Semi-
permeabilizing the cell membrane allows for addition of the ATP analog to the cell, but can
significantly alter cell signaling networks and response to stimulation. Continued
development of new methods (e.g. microinjection platforms) should enable more high
throughput analysis of kinase substrates across different time points and conditions, thereby
providing a much more comprehensive map of the signaling networks. This information
would facilitate our understanding of how signaling networks re-wire in the context of
different disease states, potentially enabling more directed therapeutic strategies to reset the
network.
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Dynamics of other PTMs and PTM crosstalk
Deciphering the regulation of other protein PTMs has proven immensely challenging due to
a combination of poor affinity capture reagents and the low-abundance/low stoichiometry of
many PTMs. Despite these challenges, several studies have now documented proteome-wide
lysine acetylation, yet none of these studies have quantified acetylation temporal dynamics
[25–27]. Novel affinity capture approaches and advancements in MS technologies have
allowed network-wide interrogation of several other PTMs. For instance, protein
palmitoylation on cysteine residues has recently been analyzed using bioorthogonal labeling
with palmitic acid analog 17-octadecynoic acid (17-ODYA) into the endogenous sites of
protein palmitoylation, and quantified with isotopic labeling strategies. This novel approach
utilized biotin-azide click chemistry and avidin enrichment for LC-MS analysis [28]. Highly
dynamic global protein palmitoylation events were defined on proteins implicated in
migration, proliferation and cancer, among others. While sites of protein ubiquitination have
recently been described using ubiquitin remnant profiling [29], a recent study has leveraged
this technique to screen for ubiquitylated sites that are dynamically regulated in response to
ultraviolet irradiation. This study uncovered a vital role for dynamic ubiquitination of PCNA
associated factor PAF15 during DNA-damage signaling [30]. Although quantification of
ubiquitin remnants provided insight into this system, further improvements to this approach
may enable selective profiling of specific monoubiquitination or polyubiquitination linkages
to illuminate how these differences regulate system-level signaling. Lastly, a recent study by
the Bonaldi group combined heavy methyl isotopic labeling, extensive immunoaffinity
enrichment of arginine/lysine methylation, and distinct separation schemes to
comprehensively investigate non-histone protein methylation in HeLa cells [31].
Another dimension of PTM regulation applies to the coexistence of multiple modifications
on the same proteins and the possibility of functional PTM crosstalk. A combinatorial PTM
code has been elegantly deciphered to show how acetylation, phosphorylation, and
methylation of histone tails leads to chromatin remodeling and modulation of gene
expression [32]. The scope and interplay of co-occurring PTMs on other proteins and
pathways is less understood, although several studies have described the interaction of
proximal acetylation and phosphorylation sites on selected proteins. Traditionally, probing
multiple PTMs simultaneously has been restricted due to compatibility of co-enrichment
methods and also by difficulties in detecting peptides concurrently modified with unrelated
PTMs. Recently, a novel platform was published to permit i) identification of proteins
comodified by ubiquitination and phosphorylation, and ii) identification of proteins where
these dual PTM marks were found in close sequence proximity [33]. Using this strategy the
extent of ubiquitylation-phosphorylation cross-talk in the context of protein degradation was
examined. Intriguingly, spatial constraints appear to be at play for some phosphorylation-
ubiquitination modification cross-talk and in some cases there can be a preferential
directionality to the regulation of PTMs occurring proximally. Other studies have
demonstrated the usefulness of systematic in silico integration of phosphorylation,
acetylation, and ubiquitination proteomics datasets to reveal PTM interplay or the
importance of PTM conservation as an indication of modifications that are more likely to
exhibit cross-talk [34,35].
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Novel tools and future challenges
The development of innovative technological advances may enhance our experimental
dissection of PTM dynamics on a network scale. For example, the ability to expand the
multiplex capacity of MS platform analysis would provide further sampling opportunities
and overall depth of quantitative coverage. The recently described neutron encoded
chemical and metabolic labeling approaches exploit subtle mass defects that occur due to
nuclear binding energy variance of stable isotopes and can extend to 12-plex quantification
in the same experiment [36,37].
As the breadth of quantitative data increases, it is worthwhile to call attention to the manner
in which this data is annotated and interpreted [38,39]. Although systems level studies serve
as a rich community resource, ambiguities in peptide identification or PTM site assignments
may exist in these datasets, often to detrimental or misleading effects [40]. Given the intent
of using proteomics PTM datasets to derive biological insight, it is imperative that the
dynamically regulated PTMs be accurately annotated and sites of modification localized
precisely. This task relies on automated database matching and scoring of identifications but
can benefit from user-assisted validation strategies [41].
With high quality large-scale databases of dynamic temporal phosphorylation profiles, a
large number of computational tools can be applied to the data to imply network structure
and gain biological insight. In one interesting approach, the Lauffenburger lab applied a
combinatorial bioinformatics algorithm (MCAM) to quantitative tyrosine phosphorylation
data describing signaling network response to EGF stimulation [42]. Intriguingly, the most
frequently co-clustered phosphorylation sites in this computational approach described site-
specific protein-protein interactions, including a novel interaction between EGFR and
PDLIM1 [43]. In another approach, the prize-collecting steiner tree algorithm utilizes
quantitative phosphorylation data and the protein-protein interactome to infer missing nodes
and connect co-regulated phosphorylated proteins into pathways and networks [44].
Additional computational tools to infer kinase-substrate relationships, such as NetworKIN,
will also benefit from high quality data describing phosphorylation dynamics [45].
In conclusion, measuring system level dynamics of PTMs has the potential to inform our
understanding of everything from fundamental biological processes to decoding the
complexity involved in disease networks. Network medicine is an emerging area of interest
and has recently witnessed an example of a potential temporal network drug (ie.
administration of combination therapy in an order- and time-dependent manner)
demonstrating the utility of system level studies [46–48]. Leveraging MS technologies to
quantify the dynamic interactions of multiple PTM networks simultaneously will make
unique contributions to how systems biology is explored.
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Highlights
• Post-translational modifications (PTMs) modulate diverse cellular functions
• PTM signaling networks are dynamic, extensive and interconnect cellular
responses
• Mass spectrometry PTM analysis can identify and quantify dynamic network
components
• Integration of dynamic PTM signal-response relationships reveals biological
insight
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